<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV), the causative agent of <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e>, is a human herpesvirus associated with epithelial cell <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> (nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp>) as well as B-cell <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Understanding how <z:mp ids='MP_0001799'>viral</z:mp> latency is disrupted is a central issue in herpesvirus biology </plain></SENT>
<SENT sid="2" pm="."><plain>Epithelial cells are the major site of lytic EBV replication within the human host, and <z:mp ids='MP_0001799'>viral</z:mp> reactivation occurs in EBV-associated nasopharyngeal <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>It is known that expression of a single <z:mp ids='MP_0001799'>viral</z:mp> immediate-early protein, BZLF1, is sufficient to initiate the switch from latent to lytic <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in B cells </plain></SENT>
<SENT sid="4" pm="."><plain>Cellular regulation of BZLF1 transcription is therefore thought to play a key role in regulating the stringency of <z:mp ids='MP_0001799'>viral</z:mp> latency </plain></SENT>
<SENT sid="5" pm="."><plain>Here we show that, unexpectedly, expression of another <z:mp ids='MP_0001799'>viral</z:mp> immediate-early protein, BRLF1, can disrupt <z:mp ids='MP_0001799'>viral</z:mp> latency in an epithelial cell-specific fashion </plain></SENT>
<SENT sid="6" pm="."><plain>Therefore, the mechanisms leading to disruption of EBV latency appear to be cell-type specific </plain></SENT>
</text></document>